Artificial Intelligence for Highly Myopic Cataract

Launched by SHANGHAI HIGH MYOPIA STUDY GROUP · Sep 25, 2024

Keywords

ClinConnect Summary

This clinical trial is investigating how artificial intelligence (AI) can help improve the treatment of cataracts in patients with high myopia, which is a condition where people see distant objects as blurry. The goal is to develop an AI model that can more accurately calculate the right type of lens needed for surgery, ensuring better vision outcomes after the procedure.

To participate in this study, individuals must have a specific eye measurement (axial length of 26 mm or more) and be diagnosed with high myopia along with cataracts. Participants will undergo a series of eye examinations before surgery and will need to follow up for at least one month after the procedure to check their healing and vision improvement. This study is currently looking for patients of all ages and genders who meet these criteria and can complete the necessary tests. If you're interested, reach out to the hospital for more information on how to get involved!

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Axial length ≥ 26 mm and patients with high myopia complicated by cataracts who visit our hospital.
• • Preoperative anterior segment photography and cataract severity assessment, along with fundus OCT examination, have been performed.
• • If surgical treatment is conducted, the postoperative follow-up period should be no less than 1 month.
• • There are no missing clinical data before and after the surgery.
• Exclusion Criteria:
• • Patients who are unable to cooperate with the required examinations for this study.